Viktor Berge

Professor II - Department of Urology
Image of Viktor Berge
Norwegian version of this page
Username
Visiting address Trondheimsveien 235 0586 Oslo
Postal address Postboks 4959 Nydalen 0424 Oslo

Publications

  • Møller, Christina Tanem; Tafjord, Gunnar; Blindheim, Augun Jodis; Berge, Viktor; Fosså, Sophie Dorothea & Kulle, Bettina (2023). Initial management and survival of patients with primary metastatic bladder cancer before the immunotherapy era: a population-based study from Norway. Scandinavian Journal of Urology. ISSN 2168-1805. 58, p. 101–108. doi: 10.2340/sju.v58.5923. Full text in Research Archive
  • Luiting, Henk Benjamin; Remmers, Sebastiaan; Boevé, Egbert R.; Valdagni, Riccardo; Chiu, Peter K. & Semjonow, Axel [Show all 11 contributors for this article] (2022). A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer-Data from the International Multicenter Prospective PRIAS Study. European Urology Oncology (EUO). ISSN 2588-9311. 5(6), p. 651–658. doi: 10.1016/j.euo.2022.03.007.
  • Møller, Christina Tanem; Støer, Nathalie Charlotte; Blindheim, Augun; Berge, Viktor; Tafjord, Gunnar & Fosså, Sophie Dorothea [Show all 7 contributors for this article] (2022). Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study. BMC Cancer. ISSN 1471-2407. 22(1). doi: 10.1186/s12885-022-10394-w. Full text in Research Archive
  • Guldvik, Ingrid Jenny; Braadland, Peder Rustøen; Sivanesan, Shivanthe ; Ramberg, Håkon Andre; Kristensen, Gitte & Tennstedt, Pierre [Show all 13 contributors for this article] (2022). Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer. European Urology Open Science. ISSN 2666-1691. 45, p. 68–75. doi: 10.1016/j.euros.2022.09.002. Full text in Research Archive
  • Møller, Christina Tanem; Fosså, Sophie Dorothea; Tafjord, Gunnar; Babigumira, Ronnie; Berge, Viktor & Kulle, Bettina (2022). Primary versus secondary muscle-invasive bladder cancer: survival after curative treatment. Scandinavian Journal of Urology. ISSN 2168-1805. 56(3), p. 214–220. doi: 10.1080/21681805.2022.2056633. Full text in Research Archive
  • Ouellet, Véronique; Erickson, Andrew; Wiley, Kathy; Morrissey, Colm; Berge, Viktor & Moreno, Carlos S. [Show all 31 contributors for this article] (2022). The movember global action plan 1 (GAP1): Unique prostate cancer tissue microarray resource. Cancer Epidemiology, Biomarkers and Prevention. ISSN 1055-9965. 31(4), p. 715–727. doi: 10.1158/1055-9965.EPI-21-0600. Full text in Research Archive
  • Hopland, Ola Andreas; Fosså, Sophie Dorothea; Ottosson, Fredrik; Brennhovd, Bjørn; Svindland, Aud & Hole, Knut Håkon [Show all 10 contributors for this article] (2021). Robotic salvage pelvic lymph node dissection for locoregional recurrence after radical prostatectomy: a single institution experience. Scandinavian Journal of Urology. ISSN 2168-1805. 55(4). doi: 10.1080/21681805.2021.1946135. Full text in Research Archive
  • Thiem, Barbara; Kruszka, Dariusz; Turowska, Natalia; Sliwinska, Elwira; Berge, Viktor & Kikowska, Małgorzata (2021). Linnaea borealis L. Var. borealis—In vitro cultures and phytochemical screening as a dual strategy for its ex situ conservation and a source of bioactive compounds of the rare species. Molecules. ISSN 1431-5157. 26(22). doi: 10.3390/molecules26226823. Full text in Research Archive
  • Ramirez, Manuel; Berge, Viktor; Linē, Aija & Llorente, Alicia (2021). Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients. British Journal of Cancer. ISSN 0007-0920. 126, p. 492–501. doi: 10.1038/s41416-021-01598-1. Full text in Research Archive
  • Aas, Kirsti; Berge, Viktor; Myklebust, Tor Åge & Fosså, Sophie Dorothea (2021). Comparative survival outcomes of high-risk prostate cancer ttreated with radical prostatectomy or definitive radiotherapy regimens. European Urology Open Science. ISSN 2666-1691. 26, p. 55–63. doi: 10.1016/j.euros.2021.01.011. Full text in Research Archive
  • Moghaddam, Shirin; Jalali, Amirhossein; O’neill, Amanda; Murphy, Lisa; Gorman, Laura & Reilly, Anne-Marie [Show all 16 contributors for this article] (2021). Integrating serum biomarkers into prediction models for biochemical recurrence following radical prostatectomy. Cancers. ISSN 2072-6694. 13(16), p. 1–11. doi: 10.3390/cancers13164162. Full text in Research Archive
  • Ramberg, Håkon Andre; Richardsen, Elin; De Souza, Gustavo Antonio; Rakaee, Mehrdad; Stensland, Maria & Braadland, Peder Rustøen [Show all 13 contributors for this article] (2021). Proteomic analyses identify major vault protein as a prognostic biomarker for fatal prostate cancer. Carcinogenesis. ISSN 0143-3334. 42(5), p. 685–693. doi: 10.1093/carcin/bgab015. Full text in Research Archive
  • Aas, Kirsti; Fosså, Sophie Dorothea; Myklebust, Tor Åge; Møller, Bjørn; Kvåle, Rune & Vlatkovic, Ljiljana [Show all 7 contributors for this article] (2020). Increased curative treatment is associated with decreased prostate cancer-specific and overall mortality in senior adults with high-risk prostate cancer; results from a national registry-based cohort study. Cancer Medicine. ISSN 2045-7634. 9(18), p. 6646–6657. doi: 10.1002/cam4.3297. Full text in Research Archive
  • Fosså, Sophie Dorothea; Beyer, Bud; Dahl, Alv A; Aas, Kirsti; Eri, Lars Magne & Kvan, Espen [Show all 10 contributors for this article] (2019). Improved patient-reported functional outcomes after nerve-sparing radical prostatectomy by using NeuroSAFE technique. Scandinavian Journal of Urology. ISSN 2168-1805. p. 1–7. doi: 10.1080/21681805.2019.1693625. Full text in Research Archive
  • Medlow, Paul Wallace; Steele, Christopher James; McCavigan, Andrena Marie; Reardon, Wesley; Brown, Christopher Michael & Lambe, Shauna May [Show all 18 contributors for this article] (2018). Analytical validation of a prognostic prostate cancer gene expression assay using formalin fixed paraffin embedded tissue. BMC Medical Genomics. ISSN 1755-8794. 11(1). doi: 10.1186/s12920-018-0442-y.
  • Jain, Suneil; Lyons, Ciara A.; Walker, Steven Michael; McQuaid, Stephen; Hynes, Seán O. & Mitchell, Darren M. [Show all 25 contributors for this article] (2018). Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy. Annals of Oncology. ISSN 0923-7534. 29(1), p. 215–222. doi: 10.1093/annonc/mdx637.
  • Aas, Kirsti; Fosså, Sophie Dorothea; Kvåle, Rune; Møller, Bjørn; Myklebust, Tor Åge & Vlatkovic, Ljiljana [Show all 8 contributors for this article] (2018). Is time from diagnosis to radical prostatectomy associated with oncological outcomes? . World Journal of Urology. ISSN 0724-4983. 37(8), p. 1571–1580. doi: 10.1007/s00345-018-2570-6.
  • Johnson, Ida; Ottosson, Fredrik; Diep, Lien My; Berg, Rolf Eigil; Hoff, Jon Roar & Wessel, Nicolai [Show all 8 contributors for this article] (2018). Switching from laparoscopic radical prostatectomy to robot assisted laparoscopic prostatectomy: comparing oncological outcomes and complications. Scandinavian Journal of Urology. ISSN 2168-1805. 52(2), p. 116–121. doi: 10.1080/21681805.2017.1420099.
  • Fan, Zhirui; Li, Lifeng; Li, Xiaoli; Zhang, Meng; Zhong, Yali & Li, Yaqing [Show all 17 contributors for this article] (2018). Generation of an oxoglutarate dehydrogenase knockout rat model and the effect of a high-fat diet. RSC Advances. ISSN 2046-2069. 8(30), p. 16636–16644. doi: 10.1039/c8ra00253c. Full text in Research Archive
  • Prencipe, Maria; Fabre, Aurelie; Murphy, Thomas Brendan; Vargyas, Eszter; O'Neill, Amanda & Bjartell, Anders [Show all 13 contributors for this article] (2018). Role of serum response factor expression in prostate cancer biochemical recurrence. The Prostate. ISSN 0270-4137. 78(10), p. 724–730. doi: 10.1002/pros.23516.
  • Li, Xiaoran; Grigalavicius, Mantas; LI, Yaqing; Li, Xiaoli; Zhong, Yali & Huang, Ruixia [Show all 12 contributors for this article] (2017). MtDNA depletion influences the transition of CD44 subtypes in human prostate cancer DU145 cells. Tumour Biology. ISSN 1010-4283. 39(8). doi: 10.1177/1010428317713671.
  • Braadland, Peder; Giskeødegård, Guro F.; Sandsmark, Elise; Bertilsson, Helena; Euceda, Leslie R. & Hansen, Ailin Falkmo [Show all 17 contributors for this article] (2017). Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy. British Journal of Cancer. ISSN 0007-0920. 117(11), p. 1656–1664. doi: 10.1038/bjc.2017.346. Full text in Research Archive
  • Aas, Kirsti; Axcrona, Karol; Kvåle, Rune; Møller, Bjørn; Myklebust, Tor Åge & Axcrona, Ulrika [Show all 8 contributors for this article] (2017). Ten-year Mortality in Men With Nonmetastatic Prostate Cancer in Norway. Urology. ISSN 0090-4295. 110, p. 140–147. doi: 10.1016/j.urology.2017.07.048.
  • Walker, Steven M.; Knight, Laura A.; McCavigan, Andrena M.; Logan, Gemma E.; Berge, Viktor & Sherif, Amir [Show all 27 contributors for this article] (2017). Molecular subgroup of primary prostate cancer presenting with metastatic biology. European Urology. ISSN 0302-2838. 72(4), p. 509–518. doi: 10.1016/j.eururo.2017.03.027. Full text in Research Archive
  • Li, Xiaoli; Han, Gaoyang; Li, Xiaoran; Kan, Qancheng; Fan, Zhirui & LI, Yaqing [Show all 14 contributors for this article] (2017). Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells. OncoTarget. ISSN 1949-2553. 8(28), p. 46363–46380. doi: 10.18632/oncotarget.18199.
  • Li, Xiaoran; Lu, Jie; Kan, Quancheng; Li, Xiaoli; Fan, Qiong & Li, Yaqing [Show all 17 contributors for this article] (2017). Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells. Scientific Reports. ISSN 2045-2322. 7:5081, p. 1–20. doi: 10.1038/s41598-017-05086-6.
  • Skotland, Tore; Ekroos, Kim; Kauhanen, Dimple; Simolin, Helena; Seierstad, Therese & Berge, Viktor [Show all 8 contributors for this article] (2017). Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers. European Journal of Cancer. ISSN 0959-8049. 70, p. 122–132. doi: 10.1016/j.ejca.2016.10.011.
  • Moen, Line Victoria; Ramberg, Håkon Andre; Zhao, Sen; Grytli, Helene Hartvedt; Sveen, Anita & Berge, Viktor [Show all 9 contributors for this article] (2017). Observed correlation between the expression levels of catalytic subunit, C?2, of cyclic adenosine monophosphate-dependent protein kinase and prostate cancer aggressiveness. Urologic Oncology. ISSN 1078-1439. 35(3), p. 111.e1–111.e8. doi: 10.1016/j.urolonc.2016.10.002.
  • Ling, Wang; Skotland, Tore; Berge, Viktor; Sandvig, Kirsten & Llorente, Alicia (2017). Exosomal proteins as prostate cancer biomarkers in urine: From mass spectrometry discovery to immunoassay-based validation. European Journal of Pharmaceutical Sciences. ISSN 0928-0987. 98, p. 80–85. doi: 10.1016/j.ejps.2016.09.023.
  • Bokhorst, Leonard P.; Lepistö, Inari; Kakehi, Yoshiyuki; Bangma, Chris H.; Pickles, Tom & Valdagni, Riccardo [Show all 13 contributors for this article] (2016). Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study. BJU International. ISSN 1464-4096. 118(3), p. 366–371. doi: 10.1111/bju.13410.
  • Ramberg, Håkon Andre; Grytli, Helene Hartvedt; Nygård, Ståle; Wang, Wanzhong; Øgren, Hans Olav & Zhao, Sen [Show all 14 contributors for this article] (2016). PBX3 is a putative biomarker of aggressive prostate cancer. International Journal of Cancer. ISSN 0020-7136. 139(8), p. 1810–1820. doi: 10.1002/ijc.30220.
  • Braadland, Peder; Grytli, Helene Hartvedt; Ramberg, Håkon Andre; Katz, Betina; Kellmann, Ralf & Gauthier-Landry, louis [Show all 18 contributors for this article] (2016). Low β2-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism . OncoTarget. ISSN 1949-2553. 7(2), p. 1878–1894. doi: 10.18632/oncotarget.6479. Full text in Research Archive
  • Rud, Erik; Baco, Eduard; Klotz, Dagmar; Rennesund, Kristin; Svindland, Aud & Berge, Viktor [Show all 13 contributors for this article] (2015). Does preoperative magnetic resonance imaging reduce the rate of positive surgical margins at radical prostatectomy in a randomised clinical trial? European Urology. ISSN 0302-2838. 68(3), p. 487–496. doi: 10.1016/j.eururo.2015.02.039.
  • Øverbye, Anders; Skotland, Tore; Koehler, Christian; Thiede, Bernd; Seierstad, Therese & Berge, Viktor [Show all 8 contributors for this article] (2015). Identification of prostate cancer biomarkers in urinary exosomes. OncoTarget. ISSN 1949-2553. 6(30), p. 30357–30376. doi: 10.18632/oncotarget.4851.
  • Dahl, Sigrun; Loge, Jon Håvard; Berge, Viktor; Dahl, Alv A; Småstuen, Milada C & Fosså, Sophie Dorothea (2015). Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery. Journal of cancer survivorship. ISSN 1932-2259. 9(2), p. 172–179. doi: 10.1007/s11764-014-0399-6.
  • Donaldson, Ian A.; Alonzi, Roberto; Barratt, Dean; Barret, Eric; Berge, Viktor & Bott, Simon [Show all 22 contributors for this article] (2015). Focal therapy: Patients, interventions, and outcomes - A report from a consensus meeting. European Urology. ISSN 0302-2838. 67(4), p. 771–777. doi: 10.1016/j.eururo.2014.09.018.
  • Rud, Per Erik; Klotz, Dagmar; Rennesund, Kristin; Baco, Eduard; Berge, Viktor & Diep, Lien My [Show all 11 contributors for this article] (2014). Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone. BJU International. ISSN 1464-4096. 114(6), p. E32–E42. doi: 10.1111/bju.12637.
  • Ahmed, Hashim Uddin; Berge, Viktor; Bottomley, David; Cross, William; Heer, Rakesh & Kaplan, Richard [Show all 16 contributors for this article] (2014). Can we deliver randomized trials of focal therapy in prostate cancer? Nature Reviews Clinical Oncology. ISSN 1759-4774. 11(8), p. 482–491. doi: 10.1038/nrclinonc.2014.44.
  • Baco, Eduard; Gelet, Albert; Crouzet, Sebastien; Rud, Per Erik; Rouviere, Olivier & Tonoli-Catez, Helene [Show all 9 contributors for this article] (2014). Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: A prospective two-centre study. BJU International. ISSN 1464-4096. 114(4), p. 532–540. doi: 10.1111/bju.12545.
  • Berge, Viktor; Dickinson, Louise; McCartan, Neil; Hindley, Richard G.; Diep, Lien My & Emberton, Mark [Show all 7 contributors for this article] (2014). Morbidity associated with primary high intensity focused ultrasound and redo high intensity focused ultrasound for localized prostate cancer. Journal of Urology. ISSN 0022-5347. 191(6), p. 1764–1769. doi: 10.1016/j.juro.2013.12.036.
  • Itkonen, Harri; Minner, S; Guldvik, Ingrid Jenny; Sandmann, M; Tsourkalis, Maria & Berge, Viktor [Show all 9 contributors for this article] (2013). O-GlcNAc Transferase Integrates Metabolic Pathways to Regulate the Stability of c-MYC in Human Prostate Cancer Cells. Cancer Research. ISSN 0008-5472. 73. doi: 10.1158/0008-5472.CAN-13-0549.
  • Berge, Viktor; Berg, Rolf Eigil; Hoff, Jon Roar; Wessel, Nicolai; Diep, Lien My & Karlsen, Steinar [Show all 7 contributors for this article] (2013). A Prospective Study of Transition From Laparoscopic to Robot-assisted Radical Prostatectomy: Quality of Life Outcomes After 36-Month Follow-up. Urology. ISSN 0090-4295. 81(4), p. 781–786. doi: 10.1016/j.urology.2013.01.017.
  • Berge, Viktor; Berg, Rolf Eigil; Hoff, Jon Roar; Wessel, Nicolai; Svindland, Aud & Karlsen, Steinar [Show all 7 contributors for this article] (2012). Five-year progression-free survival in 577 patients operated on with laparoscopic radical prostatectomy for localized prostate cancer. Scandinavian Journal of Urology and Nephrology. ISSN 0036-5599. 46(1), p. 8–13. doi: 10.3109/00365599.2011.604790.
  • Ramberg, Håkon Andre; Alshbib, Ayham; Berge, Viktor; Svindland, Aud & Tasken, Kristin Austlid (2011). Regulation of PBX3 expression by androgen and Let-7d in prostate cancer. Molecular Cancer. ISSN 1476-4598. 10. doi: 10.1186/1476-4598-10-50.
  • Berge, Viktor; Baco, Eduard; Dahl, Alv A & Karlsen, Steinar (2011). Health-related quality of life after salvage high-intensity focused ultrasound (HIFU) treatment for locally radiorecurrent prostate cancer. International journal of urology. ISSN 0919-8172. 18(9), p. 646–651. doi: 10.1111/j.1442-2042.2011.02815.x.
  • Berge, Viktor; Baco, Eduard & Karlsen, Steinar (2010). A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: Early results. Scandinavian Journal of Urology and Nephrology. ISSN 0036-5599. 44(4), p. 223–227. doi: 10.3109/00365591003727551.
  • Berge, Viktor; Johnson, Egil & Berge, Knut Erik (1996). Interleukin-1 alpha, interleukin 6 and tumor necrosis factor alpha increase the synthesis and expression of the functional alternative and terminal complement pathways by human umbilical vein endothelial cells in vitro. APMIS - Journal of Pathologiy, Microbiology and Immunology. ISSN 0903-4641. 104, p. 213–219.
  • Berge, Viktor; Berge, Knut Erik & Johnson, Egil (1996). Vitronectin modulates the expression of the terminal complement pathway synthesized by human umbilical vein endothelial cells in vitro. APMIS - Journal of Pathologiy, Microbiology and Immunology. ISSN 0903-4641. p. 523–530.
  • Berge, Viktor; Berge, Knut Erik & Johnson, Egil (1996). Vitronectin modulates the expression of complement components of the terminal pathway synthesized by human umbilical vein endothelial cells in vitro. APMIS - Journal of Pathologiy, Microbiology and Immunology. ISSN 0903-4641. 104, p. 523–530.

View all works in Cristin

  • Berge, Viktor & Beisland, Christian (2023). PSA-testen må brukes smartere. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 143(12). doi: 10.4045/tidsskr.23.0528.
  • Aas, Kirsti; Fosså, Sophie Dorothea; Kvåle, Rune; Møller, Bjørn; Myklebust, Tor Åge & Vlatkovic, Ljiljana [Show all 8 contributors for this article] (2018). Increasing Time from Diagnosis to Radical Prostatectomy (RP-interval) is Not Associated with Adverse Oncological Outcomes: Implications for cancer patient pathways (CPPs). European Urology. Supplement. ISSN 1569-9056. 17(14), p. e2825–e2827. doi: 10.1016/S1569-9056(18)33709-6.
  • Rodriguez, Marta; Bajo-Santos, Cristina; Hessvik, Nina Pettersen; Lorenz, Susanne; Fromm, Bastian & Berge, Viktor [Show all 9 contributors for this article] (2017). Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes. Molecular Cancer. ISSN 1476-4598. 16:156, p. 1–6. doi: 10.1186/s12943-017-0726-4.
  • Solberg, Arne; Angelsen, Anders; Berge, Viktor; Lilleby, Wolfgang; IVERSEN, JON REIDAR & Klepp, Olbjørn [Show all 11 contributors for this article] (2015). Re: Ulike retninglinjer for behandling av prostatakreft. Tidsskrift for Den norske legeforening. ISSN 0029-2001. 135(12/13), p. 1105–1105. doi: 10.4045/tidsskr.15.0652.
  • Baco, Eduard; Rud, Erik; Boezelijn, Gro; Berge, Viktor & Eggesbø, Heidi Beate (2013). Hemi ablation of prostate by hifu in patients with unilateral prostate cancer: a prospective study. Scandinavian Journal of Urology and Nephrology. ISSN 0036-5599. 47, p. 49–50.
  • Lundeby, Eskild; Eri, Lars Magne; Lien, My Diep; Karlsen, Steinar & Berge, Viktor (2013). Functional outcomes after conventional laparoscopic radical prostatectomy (LRP); A comparison between assessment by clinician interview vs validated health related quality of life (HRQOL) questionnaires completed by the patients. Scandinavian Journal of Urology and Nephrology. ISSN 0036-5599. 47, p. 6–6.
  • Berge, Viktor; Næss-Andresen, Thomas Fredrik; Karlsen, Steinar & Baco, Eduard (2013). Biochemical survival, urinary and sexual function at 29.1 months median follow up in patients treated with primary whole gland high intensity focused ultrasound (wgHIFU) for localized prostate cancer. Scandinavian Journal of Urology and Nephrology. ISSN 0036-5599. 47, p. 52–52.
  • Blana, A.; Berge, Viktor; Brown, Steven Randall; Chaussy, C.; Ganzer, R. & Crouzet, S. [Show all 12 contributors for this article] (2012). Localized prostate cancer control with primary HIFU therapy: Outcomes from 5663 men followed with the @-registry. European Urology. Supplement. ISSN 1569-9056. 11(1), p. E979–U53.
  • Robertson, Cary N.; Ward, John Francis; Crouzet, Sebastien; Brown, Stephen C. W.; Berge, Viktor & Chaussy, Christian G. [Show all 11 contributors for this article] (2012). Biochemical survival and morbidity of high-intensity focused ultrasound (HIFU) as a primary monotherapy for low-risk localized prostate cancer: Outcomes from the @-registry following the ENLIGHT trial inclusion criteria. Journal of Clinical Oncology. ISSN 0732-183X. 30(15).
  • Berge, Viktor (2011). Editorial Comment to Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer. International journal of urology. ISSN 0919-8172. 18(5), p. 363–364. doi: 10.1111/j.1442-2042.2011.02752.x.
  • Eri, Lars Magne; Berg, Rolf Eigil; Berge, Viktor; Hoff, Jon-Roar; Wahlqvist, Rolf & Karlsen, Steinar (2007). Laparoscopic radical prostatectomy. Our first four years. European Urology. ISSN 0302-2838. 6, p. 254–254.
  • Berge, Viktor; Baco, Eduard & Karlsen, Steinar (2007). Our first experience high intensity focused ultrasound treatment for localized prostate cancer. Scandinavian Journal of Urology and Nephrology. ISSN 0036-5599. 2007(41), p. 21–21.
  • Baco, Eduard; Berge, Viktor & Karlsen, Steinar (2007). Recurrent prostate cancer etter radikal strålebehandling. "Salvage" HIFU, foreløpige korttidserfaringer ved OUU. Vitenskapelige forhandlinger - De norske kirurgiske foreninger. ISSN 0801-5902. p. 74–74.
  • Berge, Viktor; Baco, Eduard & Karlsen, Steinar (2007). HIFU ved OUU: Nytt tilbud for pasienter med cancer prostatae. Kirurgen. ISSN 1504-8888. 1, p. 26–27.
  • Berge, Viktor (1997). STUDIES ON FACTORS REGULATING THE EXPRESSION AND SYNTHESIS OF THE FUNCTIONAL COMPONENTS OF THE ALTERNATIVE AND TERMINAL COMPLEMENT PATHWAYS BY HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS IN VITRO.

View all works in Cristin

Published May 14, 2019 12:08 PM - Last modified June 13, 2019 12:26 PM

Research groups